According to the market research, the sales of Dasatinib have increased year by year from 2016 to 2020, with the most significant growth in 2018. The annual growth rate is 48.72 % from CNY51 million in 2017 to CNY75 million in 2018. The main reason for the increase is that China has undertaken an effort to cut healthcare costs, requiring insurance to cover 70% of costs since the national drug price negotiations in 2017. The CAGR of Dasatinib sales in 2016-2020 is 28.55%.
The analyst analyzes that its sales will have an upward trend from 2021 to 2025 as the Chinese Dasatinib market expands. At present, 3 companies in China are in the approval stage of Dasatinib generic drugs. After the success of the approvals, the competition in the Chinese Dasatinib market will become more intense and the price will be less than before. Hence, the sales volume will increase accordingly. In addition, Dasatinib has been approved for 4 indications internationally, and only 2 indications have been approved in China. The number of indications approved in China is likely to increase, then sales still have the potential to increase.
- The impact of COVID-19 on China's Dasatinib market
- Sales value of China's Dasatinib 2016-2020
- Competitive landscape of China's Dasatinib market
- Prices of Dasatinib in China
- Prices of Dasatinib in China by regions and manufacturers
- Analysis of factors affecting the development of China's Dasatinib market
- Prospect of China's Dasatinib market from 2021 to 2025
1.2 Development of Dasatinib in China
1.3 Governmental Approval of Dasatinib in China
1.4 The Impact of COVID-19 on Dasatinib sales in China
2.1.1 Overall Sales Value
2.1.2 Sales Value by Regions
2.2 Sales Volume of Dasatinib
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Dasatinib by Dosage Form in China, 2016-2020
2.3.2 Analysis of Other Dosage Forms
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales Volume
3.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Yinishu (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s Dasatinib) in China
3.3 Bristol-Myers Squibb Pharma EEIG
3.3.1 Enterprise Profile
3.3.2 Sales of SPRYCEL (Bristol-Myers Squibb Pharma EEIG's Dasatinib) in China
4.2 Bristol-Myers Squibb Pharma EEIG (SPRYCEL)
5.1.1 The Impact of COVID-19 on Chinese Dasatinib Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
Chart Sales Value of Dasatinib Tablet over the World
Chart Sales Value of Dasatinib Tablet in China, 2016-2020
Chart Sales Value of Dasatinib Tablet in China by Regions, 2016-2020
Chart Sales Volume of Dasatinib Tablet in China, 2016-2020
Chart Sales Volume of Dasatinib Tablet in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Dasatinib Manufacturers in China, 2016-2020
Chart Sales Value and Volume of Yinish in China, 2016-2020
Chart Sales Value and Volume of SPRYCEL in China, 2016-2020
Chart Referential Prices of Yinish in China by Regions, 2020-2021
Chart Referential Prices of SPRYCEL in China by Regions, 2020-2021
Chart Forecast on Sales Value of Dasatinib in China, 2021-2025
Chart Forecast on Sales Volume of Dasatinib in China, 2021-2025
- Bristol-Myers Squibb Pharma EEIG
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.